Next Article in Journal
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
Previous Article in Journal
Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1
Open AccessCorrection

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19

1
MRC North West Hub for Trials Methodology Research, Liverpool L69 3GL, UK
2
Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3GL, UK
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2018, 8(2), 18; https://doi.org/10.3390/jpm8020018
Received: 30 April 2018 / Revised: 2 May 2018 / Accepted: 2 May 2018 / Published: 7 May 2018
The authors wish to make the following corrections to this paper [1] [...]
View Full-Text
MDPI and ACS Style

Antoniou, M.; Jorgensen, A.L.; Kolamunnage-Dona, R. Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19. J. Pers. Med. 2018, 8, 18.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop